- Home
- PSHG vs OSRH Comparison
PSHG vs OSRH Comparison
Compare PSHG & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PSHG | OSRH |
|---|---|---|
| Founded | 2010 | N/A |
| Country | Greece | United States |
| Employees | N/A | 22 |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9M | 17.9M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | PSHG | OSRH |
|---|---|---|
| Price | $1.80 | $0.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 39.4K | ★ 666.4K |
| Earning Date | 05-26-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $49.57 | $9.30 |
| Revenue Next Year | $2.73 | N/A |
| P/E Ratio | $1.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.61 | $0.30 |
| 52 Week High | $2.58 | $1.24 |
Technical Indicators
Market Signals| Indicator | PSHG | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 56.44 | 56.63 |
| Support Level | $1.71 | $0.45 |
| Resistance Level | $1.89 | $0.45 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 60.42 | 60.39 |
Price Performance
Historical ComparisonAbout PSHG Performance Shipping Inc.
Performance Shipping Inc is a shipping company. The company is a provider of shipping transportation services through the ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying container vessels and cargo along various shipping routes. It owns and operates Aframax and Suezmax tanker vessels.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.